Novacyt FY revenues surge on demand for Covid-19 products
29th Jan 2021 09:43
(Sharecast News) - Clinical diagnostics firm Novacyt said on Friday that full-year revenues had surged in 2020, driven by the continued successful global commercialisation of its Covid-19 product portfolio.
Read moreNovacyt taps James McCarthy as new CFO
5th Jan 2021 10:53
(Sharecast News) - Clinical diagnostics company Novacyt announced on Tuesday that James McCarthy has been appointed as chief financial officer, while Anthony Dyer has taken on a new role as chief corporate development officer (CCDO).
Read moreNovacyt says its tests can detect new Covid strain, shares surge
21st Dec 2020 10:07
(Sharecast News) - Novacyt shares surged on Monday after the clinical diagnostics specialist said that its tests can detect the new strain of Covid-19 identified by the UK's Genomics consortium, known as VUI-202012/01.
Read moreNovacyt releases new tests for Covid-19, bird flu
14th Dec 2020 16:16
(Sharecast News) - Clinical diagnostics company Novacyt announced the launch of its research-use-only polymerase chain reaction test for a new strain of Covid-19 on Monday, as well as the development of two new research-use0only polymerase chain reaction tests for avian influenza, following recent outbreaks across Europe.
Read moreNovacyt swings to profit on soaring Covid test sales
17th Sep 2020 08:15
(Sharecast News) - Covid-19 test maker Novacyt swung to a first-half profit driven by soaring sales during the current pandemic and said it expected core annual earnings to top €100m.
Read moreNovacyt launches two-gene target test for Covid-19
4th Sep 2020 10:37
(Sharecast News) - Clinical diagnostics company Novacyt announced on Friday that it has launched a CE-marked polymerase chain reaction (PCR) two-gene target test for Covid-19.
Read moreNovacyt revenues surge in H1 amid demand for Covid-19 testing kit
13th Jul 2020 09:08
(Sharecast News) - Clinical diagnostics group Novacyt said first-half revenues surged as demand for its Covid-19 testing kit was expected to continue into 2021.
Read moreNovacyt launches new Covid-19 test, extraction kits
18th Jun 2020 09:33
(Sharecast News) - Clinical diagnostics firm Novacyt launched three new products aimed at supporting laboratories testing for Covid-19 on Thursday.
Read moreNovacyt to settle debt with HEGC and Vatel
3rd Jun 2020 12:28
(Sharecast News) - Clinical diagnostics company Novacyt will settle all outstanding debt obligations with Harbert European Growth Capital (HEGC) and Vatel Capital, it announced on Wednesday.
Read moreNovacyt secures further Covid-19 detection contracts
2nd Jun 2020 09:05
(Sharecast News) - Clinical diagnostics firm Novacyt secured more contract wins for its Primerdesign Covid-19 detection test, but also cautioned that it had suffered a slight setback in France.
Read moreNovacyt expands Covid test capacity further as orders roll in
29th Apr 2020 12:43
(Sharecast News) - Novacyt said on Wednesday that its subsidiary Primerdesign has sold, received orders for or has been contracted to deliver more than ?90m of its Covid-19 test.
Read moreNovacyt to supply UK govt with Covid-19 tests
27th Apr 2020 09:49
(Sharecast News) - Healthcare company Novacyt said it had signed a contract with the UK Department of Health to supply its Covid-19 polymerase chain reaction test.
Read moreNovacyt's Covid-19 diagnostic test gets OK for WHO procurement
8th Apr 2020 11:16
(Sharecast News) - Biotech group Novacyt said its Covid-19 diagnostic test had been deemed eligible for procurement under the World Health Organisation's Emergency Use Listing process.
Read moreNovacyt signs manufacturing deal with Yourgene for Covid test
25th Mar 2020 14:50
(Sharecast News) - Clinical diagnostics company Novacyt announced on Wednesday that it has signed an agreement for certain contract manufacturing services with molecular diagnostics firm Yourgene Health.
Read moreNovacyt gets US approval for Covid-19 test
23rd Mar 2020 09:54
(Sharecast News) - Novacyt said on Monday that the US Food and Drug Administration has issued an emergency use authorisation for its Covid-19 test.
Read more